Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Medi Assist Healthcare Services Limited (MEDIASSIST) AI Stock Analysis

3 Followers
IN:MEDIASSIST

Medi Assist Healthcare Services Limited

(NSE:MEDIASSIST)

Select Model
Rating:59Neutral
Price Target:INR 294.00â–²(4.51% Upside)
Action:reiterated
Date:08/17/26

The score is supported primarily by strong financial fundamentals—especially solid revenue growth and a strong, low-leverage balance sheet. However, weak technical trend/momentum and mixed cash-flow conversion (along with some margin compression) materially reduce the overall rating, while valuation appears moderate-to-premium based on the current P/E.

Positive Factors
Strong Revenue GrowthSustained revenue expansion indicates that Medi Assist is increasing the scale of its healthcare administration activities and customer base. Continued top-line growth can support operating investment, strengthen its position with insurers and payers, and provide a durable foundation for earnings over the next several quarters.
Negative Factors
Margin CompressionMargin compression means Medi Assist is converting recent revenue growth into profitability less efficiently than before. If this persists, the company may need greater operating scale or tighter cost control to restore earnings leverage, limiting the profit benefit of continued expansion in administration volumes.

Medi Assist Healthcare Services Limited (MEDIASSIST) vs. iShares MSCI India ETF (INDA)

-40%-30%-20%-10%0%10%IN:MEDIASSIST-38.25%INDA-5.86%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
INR 20.98B
Dividend Yield
0.71%
Average Volume (3M)
19.77K
Price to Earnings (P/E)
19.4
Beta (1Y)
0.98
Revenue Growth
20.27%
EPS Growth
24.08%
Country
India
Employees
6,661
Sector
General
Sector Strength
55
Industry
Asset Management

Medi Assist Healthcare Services Limited Business Overview & Revenue Model

Company Description

Medi Assist Healthcare Services is a health-tech and insur-tech company that provides third-party administration (TPA) services to insurance companies. It serves as an intermediary between insurance companies and policyholders, insurance companies an...

How the Company Makes Money

MEDIASSIST primarily makes money by providing outsourced health benefits administration services to organizations that finance healthcare (typically health insurance companies and other healthcare payers). Its key revenue streams generally include: (...

Medi Assist Healthcare Services Limited Financial Statement Overview

Summary

Strong revenue growth and a conservatively financed balance sheet (low latest debt-to-equity) support a solid financial profile. Offsetting this, profitability has seen margin compression and cash-flow quality is mixed, with volatile free cash flow and weaker conversion versus net income in the latest year.

Income Statement

68Positive

Balance Sheet

83Very Positive

Cash Flow

56Neutral
Financial statement breakdown
BreakdownTTMMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Income Statement
Total Revenue9.60B9.05B7.23B6.35B5.05B3.94B
Gross Profit2.14B5.11B4.17B2.62B2.12B1.98B
EBITDA1.85B1.79B1.78B1.31B1.33B1.12B
Net Income1.07B878.89M908.79M669.39M740.59M642.18M
Balance Sheet
Total Assets14.41B13.72B11.58B8.51B7.06B6.02B
Cash, Cash Equivalents and Short-Term Investments2.29B2.39B4.56B2.33B2.54B2.50B
Total Debt461.18M543.98M2.04B263.31M306.79M274.78M
Total Liabilities5.55B5.20B6.06B3.69B3.22B2.63B
Stockholders Equity8.84B8.39B5.41B4.72B3.77B3.37B
Cash Flow
Free Cash Flow0521.21M922.93M479.57M534.10M527.03M
Operating Cash Flow01.08B1.38B663.81M810.79M643.99M
Investing Cash Flow0-1.64B-2.18B-548.64M-104.88M-828.99M
Financing Cash Flow0264.67M1.12B-147.55M-315.25M-303.71M

Medi Assist Healthcare Services Limited Technical Analysis

Technical Analysis SentimentNegative
Last Price281.30

Price Trends

50DMA306.48Negative
100DMA329.91Negative
200DMA346.82Negative

Market Momentum

MACD-7.25Positive
RSI39.73Neutral
STOCH8.40Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For IN:MEDIASSIST, the sentiment is Negative. The current price of 281.30 is below the 20-day moving average (MA) of 290.47, below the 50-day MA of 306.48, and below the 200-day MA of 346.82, indicating a bearish trend. The MACD of -7.25 indicates Positive momentum. The RSI at 39.73 is Neutral, neither overbought nor oversold. The STOCH value of 8.40 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for IN:MEDIASSIST.

Medi Assist Healthcare Services Limited Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

IN:MEDIASSIST against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
IN:LALPATHLABIN:LALPATHLAB82OutperformINR 334.31B57.14―0.88%16.71%9.15%
IN:MEDIASSISTIN:MEDIASSIST59NeutralINR 21.01B19.40―0.71%20.27%24.08%
IN:METROPOLISIN:METROPOLIS59NeutralINR 116.93B52.14―0.35%19.84%41.41%
IN:STARHEALTHIN:STARHEALTH58NeutralINR 336.29B31.99――20.54%97.48%
IN:MEDPLUSIN:MEDPLUS56NeutralINR 74.11B35.20――20.57%7.88%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
IN:NIVABUPAIN:NIVABUPA49NeutralINR 145.55B27.35――58.19%467.19%

* General Sector Average

Performance Comparison

-40%-20%0%20%IN:MEDIASSISTIN:LALPATHLABIN:MEDPLUSIN:METROPOLISIN:NIVABUPAIN:STARHEALTHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
IN:MEDIASSIST and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
IN:MEDIASSISTMedi Assist Healthcare Services Limited281.30-181.57-39.23%
IN:LALPATHLABDr. Lal PathLabs Limited1991.75428.6927.43%
IN:MEDPLUSMedPlus Health Services Ltd.616.80-170.45-21.65%
IN:METROPOLISMetropolis Healthcare Ltd.563.6069.6714.11%
IN:NIVABUPANiva Bupa Health Insurance Company Limited78.690.720.92%
IN:STARHEALTHStar Health & Allied Insurance Co. Ltd.571.3051.659.94%

Medi Assist Healthcare Services Limited Corporate Events

Medi Assist H1 FY27 EBITDA Rises 19% as Margins Expand

Nov 1, 2026

Medi Assist reported 13.0% year-on-year growth in H1 FY27 operating revenue to ₹478.0 crore, while EBITDA rose 19.0% to ₹97.2 crore and margins expanded to 20.3%. Profit before tax increased 47.0% and profit after tax grew 59.5%, with the debt-free c...

Medi Assist Releases Q2 and H1FY27 Investor Presentation

Nov 1, 2026

Medi Assist Healthcare Services Limited has released its investor presentation covering the second quarter and first half of fiscal 2027. The disclosure gives investors updated company information and supports regulatory transparency, though the rele...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 17, 2026